![Medsafe Guidelines on the Regulation of Therapeutic Products: Specific Aspects](https://www.regdesk.co/wp-content/uploads/2024/07/Medsafe-on-regulations-specific-aspects.jpg)
Jul 12, 2024
GRTPNZ
The new article provides further clarifications on certain specific aspects associated with the regulatory requirements healthcare products, including medicines and medical devices, should comply with in order to be allowed for marketing and use in New Zealand.
Read More
![Medsafe Guidelines on the Regulation of Therapeutic Products: Categorization](https://www.regdesk.co/wp-content/uploads/2024/07/Medsafe-on-regulations-product-categories.jpg)
Jul 12, 2024
Medsafe
The new article explains the approach to be applied with respect to different categories of healthcare products based on specific criteria.
Read More
![MDCG Guidance on Conformity Assessment and Notified Bodies: Overview](https://www.regdesk.co/wp-content/uploads/2024/07/MDCG-on-CABs-and-NBs-overview-and-pre-assessment.jpg)
Jul 12, 2024
EU
The article provides a general overview of the existing legal framework for special authorized bodies undertaking special functions with respect to medical devices.
Read More
![MDCG Guidance on Conformity Assessment and Notified Bodies: On-Site Assessment](https://www.regdesk.co/wp-content/uploads/2024/07/01.jpg)
Jul 12, 2024
EU
The new article elaborates further on the matters related to on-site assessment activities to be undertaken in the context of the designation process.
Read More
![BfArM Guidance on Statistical Requirements for Clinical Trial Authorization](https://www.regdesk.co/wp-content/uploads/2024/07/BfArM-on-statistical-requirements-for-clinical-trials-1.jpg)
Jul 8, 2024
BfArM
The article provides an overview of the authorization process for clinical trials involving medical devices to be conducted in Germany.
Read More